CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash provided by operating activities
Net income	$ 45,992	$ 17,936
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of intangible assets	1,095	1,309
Depreciation	2,836	2,925
Amortization of right-of-use assets	3,967	3,494
Stock-based compensation expense	52	132
Amortization of financing fees	348	938
Deferred income taxes	162	131
(Credit) provision for losses in accounts receivable	(2,085)	2,998
Increase in allowance for inventory obsolescence	2,498	2,560
Other adjustments, net	45	3
Changes in operating assets and liabilities:
Accounts receivable	(8,428)	15,476
Inventories	(19,133)	23,611
Prepaid expenses	(7,268)	4,097
Contract assets	(4,452)	(12,048)
Other assets	149	(1,184)
Accounts payable	9,164	(1,268)
Income taxes receivable	(116)	0
Accrued expenses	7,694	2,638
Other noncurrent liabilities	(2,781)	(1,631)
Net cash provided by operating activities	29,739	62,117
Cash used in investing activities
Capital expenditures	(1,957)	(2,678)
Net cash used in investing activities	(1,957)	(2,678)
Cash used in financing activities
Repayment of long-term debt and lease liabilities	(153)	(161)
Proceeds from short-term financings	100,000	0
Repayment of short-term financings	(109,820)	(50,593)
Payments of deferred financing costs	(709)	(983)
Tax benefit from exercise of stock based compensation	(21)	0
Other financing activities, net	0	(2)
Net cash used in financing activities	(10,703)	(51,739)
Net increase in cash, cash equivalents, and restricted cash	17,079	7,700
Cash, cash equivalents, and restricted cash at beginning of the period	26,594	27,900
Cash, cash equivalents, and restricted cash at end of the period	43,673	35,600
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets
Cash and cash equivalents	40,456	31,793
Restricted cash	3,217	3,807
Total cash, cash equivalents, and restricted cash	$ 43,673	$ 35,600